The concentration of potassium in the brain's extracellular fluid ([K]ECF) is tightly regulated despite acute or chronic changes in the plasma potassium concentration. However, we have observed in three different animal models of hypertension that [K]ECF in brain is significantly reduced compared to normotensive control animals. Furthermore, chronic infusions of small amounts of potassium into the cerebral ventricles of DOCA-salt rats prevents the development of hypertension. Consequently, we hypothesize that the regulatory systems that are involved in controlling [K]ECF in brain also control blood pressure. This project is designed to provide further support for this hypothesis and to examine the roles of two regulatory systems that may control both brain [K]ECF and blood pressure.
The specific aims are to: 1) determine the relationship between blood pressure and [K]ECF of brain in normotensive and hypertensive animals and during central or dietary potassium supplementation. 2) identify the abnormality in brain potassium homeostasis which accounts for the decreased [K]ECF in hypertensive animals. 3) determine the roles of the sympathetic nervous system and brain ouabain-like factor in regulation of brain [K]ECF. Many previous clinical and animal studies have suggested an inverse relation between dietary potassium intake and blood pressure. Our studies could define the physiological basis for this relationship while, at the same time, providing new information on how [K]ECF is regulated. The demonstration that [K]ECF is the important potassium-related variable in hypertension could ultimately lead to new therapeutic approaches.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL018575-21
Application #
5213206
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
21
Fiscal Year
1996
Total Cost
Indirect Cost
Rocchini, Albert P; Yang, John Q; Smith, Marla J et al. (2010) Serial changes in norepinephrine kinetics associated with feeding dogs a high-fat diet. J Clin Hypertens (Greenwich) 12:117-24
Kamal, Mohamed A; Keep, Richard F; Smith, David E (2008) Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity. Drug Metab Pharmacokinet 23:236-42
Duan, Sheng Zhong; Ivashchenko, Christine Y; Whitesall, Steven E et al. (2007) Direct monitoring pressure overload predicts cardiac hypertrophy in mice. Physiol Meas 28:1329-39
Hu, Yongjun; Shen, Hong; Keep, Richard F et al. (2007) Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J Neurochem 103:2058-65
Ennis, Steven R; Keep, Richard F (2007) Effect of sustained-mild and transient-severe hyperglycemia on ischemia-induced blood-brain barrier opening. J Cereb Blood Flow Metab 27:1573-82
Shen, Hong; Ocheltree, Scott M; Hu, Yongjun et al. (2007) Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos 35:1209-16
Xiang, Jianming; Chiang, Pei-Pei; Hu, Yongjun et al. (2006) Role of PEPT2 in glycylsarcosine transport in astrocyte and glioma cultures. Neurosci Lett 396:225-9
Ennis, S R; Keep, R F (2006) Effects of 2,4-dinitrophenol on ischemia-induced blood-brain barrier disruption. Acta Neurochir Suppl 96:295-8
Carello, Katari A; Whitesall, Steven E; Lloyd, Mary C et al. (2006) Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats. Am J Physiol Heart Circ Physiol 290:H209-16
Xiang, Jianming; Hu, Yongjun; Smith, David E et al. (2006) PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes. Brain Res 1122:18-23

Showing the most recent 10 out of 291 publications